---
title: "Lixte Biotechnology (LIXT.US) — 財務報表"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/LIXT.US/norm.md"
symbol: "LIXT.US"
name: "Lixte Biotechnology"
parent: "https://longbridge.com/zh-HK/quote/LIXT.US.md"
datetime: "2026-05-22T00:19:28.406Z"
locales:
  - [en](https://longbridge.com/en/quote/LIXT.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/LIXT.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/LIXT.US/norm.md)
---

# Lixte Biotechnology (LIXT.US) — 財務報表

## 損益表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.1800 | -0.3220 | -0.3291 | -0.2851 | -0.2871 |
| ROE | -97.83% | -199.20% | -539.68% | 367.31% | 113.22% |
| 營業收入 | - | - | - | - | - |
| 凈利潤 | -1.94M | -2.56M | -2.03M | -775673.00 | -709555.00 |
| 營業利潤 | -1.99M | -1.82M | -1.80M | -774809.00 | -706940.00 |
| 毛利率 | - | - | - | - | - |
| 凈利率 | - | - | - | - | - |
| 利潤含金量 | - | - | - | - | - |

## 資產負債表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 資產與負債 | 10.87M | 12.73M | 5.43M | 1.19M | 1.51M |
| 權益乘數 | 1.18 | 1.16 | 1.11 | 1.82 | 1.31 |
| 每股凈資產 | 0.6830 | 0.9024 | 0.4135 | 0.2363 | -0.8721 |
| 資產周轉率 | - | - | - | - | - |
| 現金及短投 | 3.25M | 5.11M | 2.89M | 887212.00 | 1.38M |
| 存貨與應收 | - | - | - | - | - |
| 長期投資 | 7.46M | 7.56M | - | - | - |
| 凈債務 | -2.19M | -4.07M | -2.89M | -887212.00 | -1.38M |

## 現金流量表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 經營現金流 | -1.83M | -1.09M | -926752.00 | -487485.00 | -568483.00 |
| 投資現金流 | -24859.00 | -535102.00 | -2.64M | - | - |
| 融資現金流 | - | 3.84M | 5.56M | -10000.00 | 914228.00 |
| 自由現金流 | -1.46M | 1.83M | -2.81M | -7242.00 | -328266.00 |
| 現金流充裕率 | -7367.00% | -1143.93% | - | - | - |
| 舉債與償債 | - | - | - | - | - |
| 資本支出 | -24859.00 | -95102.00 | - | - | - |